Santa Farma, which was incorporated
in 1944 as a privately-owned pharmaceutical company, celebrates its 75th
anniversary in pharma industry. Within the framework of successful
business results since its establishment, Santa Farma ranks among the leading
pharmaceutical companies in Turkey with an annual turnover of 100 million USD.
Aiming to become a local and global contract manufacturing hub for internationally renowned companies, Santa Farma adopted modern production techniques in its brand-new, state-of-the-art manufacturing facility, which is EU-GMP certified. This modern facility has a capacity of 150 million units/shift and the ability to produce solids, semi solids, effervescent tablets and liquids, including a number of specialized forms, such as sachets, pellets, tab-in-caps and bilayer tablets.
Santa Farma currently offers products developed in its R&D center and manufactured in its premises in 10 different therapeutic categories both in local market and in 45 countries in CIS, Asia, Sub-Saharan Africa and Latin America.
Following cooperation models are offered by Santa Farma:
o Supplying Finished dosage form using distributorship model or private labelling
o Technology transfer
o Contract manufacturing
o Co-development / Contract development
Middle East Region (e.g. UAE); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Categories affiliated with Santa Farma Ilac San. A.S.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation